f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "b876976a-adfe-4c30-aef2-f11b31e7f918", | | "id": "b876976a-adfe-4c30-aef2-f11b31e7f918", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:12:11.650886", | | "metadata_created": "2021-09-16T08:12:11.650886", |
n | "metadata_modified": "2022-04-28T13:28:04.761677", | n | "metadata_modified": "2022-04-28T13:29:09.537478", |
| "name": "malawi-integrated-hiv-program-report-2018-q2", | | "name": "malawi-integrated-hiv-program-report-2018-q2", |
| "notes": "* Scale-up of integrated HIV services had reached the | | "notes": "* Scale-up of integrated HIV services had reached the |
| following number of sites:\r\n\r\n * __752__ static and 225 | | following number of sites:\r\n\r\n * __752__ static and 225 |
| outreach HIV testing sites\r\n\r\n * __744__ (static) ART sites; | | outreach HIV testing sites\r\n\r\n * __744__ (static) ART sites; |
t | 617 of these started at least one pregnant or breastfeeding\r\n\r\n | t | 617 of these started at least one pregnant or breastfeeding\r\n\r\n |
| woman and 709 started asymptomatic patients (Test & Treat) this | | woman and 709 started asymptomatic patients (Test & Treat) this |
| quarter\r\n\r\n * __681__ sites with HIV-exposed children in | | quarter\r\n\r\n * __681__ sites with HIV-exposed children in |
| follow-up\r\n\r\n* __1,133,277__ persons were tested for HIV and | | follow-up\r\n\r\n* __1,133,277__ persons were tested for HIV and |
| received their results; __271,901 (24%)__ accessed HIV testing for the | | received their results; __271,901 (24%)__ accessed HIV testing for the |
| first time; __861,326 (74%)__ were repeat testers and __39,432 (5%)__ | | first time; __861,326 (74%)__ were repeat testers and __39,432 (5%)__ |
| of these received confirmatory testing (after having tested positive | | of these received confirmatory testing (after having tested positive |
| in the past). __34,414 (3.1%)__ clients received a positive result for | | in the past). __34,414 (3.1%)__ clients received a positive result for |
| the first time.\r\n\r\n* __21,111 (97%)__ of __21,874__ blood units | | the first time.\r\n\r\n* __21,111 (97%)__ of __21,874__ blood units |
| collected were screened for (at least) HIV, hepatitis B and | | collected were screened for (at least) HIV, hepatitis B and |
| syphilis.\r\n\r\n* __157,822 (98%)__ of __163,363__ women at ANC had | | syphilis.\r\n\r\n* __157,822 (98%)__ of __163,363__ women at ANC had |
| their HIV status ascertained; __11,435 (8%)__ of these were HIV | | their HIV status ascertained; __11,435 (8%)__ of these were HIV |
| positive. __144,426 (99%)__ of __145,489__ women at maternity had | | positive. __144,426 (99%)__ of __145,489__ women at maternity had |
| their HIV status ascertained __10,253 (7%)__ of these were HIV | | their HIV status ascertained __10,253 (7%)__ of these were HIV |
| positive.\r\n\r\n* __31,371__ patients started ART this quarter; 64% | | positive.\r\n\r\n* __31,371__ patients started ART this quarter; 64% |
| were classified as asymptomatic / in WHO stage 1 and started under the | | were classified as asymptomatic / in WHO stage 1 and started under the |
| new \u201cTest & Treat\u201d policy.\r\n\r\n* __782,144__ patients | | new \u201cTest & Treat\u201d policy.\r\n\r\n* __782,144__ patients |
| were alive and on ART by end of June 2018. This means that 73% of the | | were alive and on ART by end of June 2018. This means that 73% of the |
| estimated __1,058,000__ HIV positive population was on ART. ART | | estimated __1,058,000__ HIV positive population was on ART. ART |
| coverage was __68% (46,140 / 68,000)__ for children and __74% (736,004 | | coverage was __68% (46,140 / 68,000)__ for children and __74% (736,004 |
| / 990,000)__ for adults.\r\n\r\n* __67,710 (88%) of 76,911__ viral | | / 990,000)__ for adults.\r\n\r\n* __67,710 (88%) of 76,911__ viral |
| load results from routine monitoring were <1000 copies/ml. Viral | | load results from routine monitoring were <1000 copies/ml. Viral |
| suppression rates for routine samples among children (0-14 years) and | | suppression rates for routine samples among children (0-14 years) and |
| adults (15+ years) were 55% and 89%, respectively.\r\n\r\n* __74%__ of | | adults (15+ years) were 55% and 89%, respectively.\r\n\r\n* __74%__ of |
| adults and __78%__ of children were retained alive on ART at 12 months | | adults and __78%__ of children were retained alive on ART at 12 months |
| after\r\ninitiation.\r\n\r\n* __675,538 (93%) of 730,071__ patients on | | after\r\ninitiation.\r\n\r\n* __675,538 (93%) of 730,071__ patients on |
| first line adult ART were on TDF/3TC/EFV.\r\n\r\n* __12,474 4 (89%)__ | | first line adult ART were on TDF/3TC/EFV.\r\n\r\n* __12,474 4 (89%)__ |
| of an estimated __14,000__ HIV infected pregnant women in Malawi were | | of an estimated __14,000__ HIV infected pregnant women in Malawi were |
| on ART this quarter. __8,668 (69%)__ of these were already on ART when | | on ART this quarter. __8,668 (69%)__ of these were already on ART when |
| getting pregnant and __3,806 (31%)__ started ART during | | getting pregnant and __3,806 (31%)__ started ART during |
| pregnancy/delivery.\r\n\r\n* An additional __1,313__ breastfeeding | | pregnancy/delivery.\r\n\r\n* An additional __1,313__ breastfeeding |
| women started ART in WHO stage 1 or 2.\r\n\r\n* __77%, 74%, 69% and | | women started ART in WHO stage 1 or 2.\r\n\r\n* __77%, 74%, 69% and |
| 64%__ of women started while pregnant or breastfeeding were retained | | 64%__ of women started while pregnant or breastfeeding were retained |
| on ART at 6, 12, 24 and 36 months after initiation, | | on ART at 6, 12, 24 and 36 months after initiation, |
| respectively.\r\n\r\n* __9,550 (7%)__ of infants discharged alive from | | respectively.\r\n\r\n* __9,550 (7%)__ of infants discharged alive from |
| maternity were known to be HIV exposed, __9,039 (95%)__ of these | | maternity were known to be HIV exposed, __9,039 (95%)__ of these |
| received ARV prophylaxis (nevirapine). __11,405__ were enrolled in | | received ARV prophylaxis (nevirapine). __11,405__ were enrolled in |
| exposed child follow-up before age 2 months.\r\n\r\n* A total of | | exposed child follow-up before age 2 months.\r\n\r\n* A total of |
| __14,508__ HIV exposed children were newly enrolled for follow-up | | __14,508__ HIV exposed children were newly enrolled for follow-up |
| this\r\nquarter.", | | this\r\nquarter.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:57:14.903501", | | "created": "2022-03-23T19:57:14.903501", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "ab4c2045-a7e5-4954-9237-9fb8cb881528", | | "id": "ab4c2045-a7e5-4954-9237-9fb8cb881528", |
| "last_modified": "2022-03-29T09:26:39.332345", | | "last_modified": "2022-03-29T09:26:39.332345", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2018-q2", | | "dha/malawi-integrated-hiv-program-report-2018-q2", |
| "metadata_modified": "2022-03-29T09:26:39.355964", | | "metadata_modified": "2022-03-29T09:26:39.355964", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2018-q2", | | "name": "malawi-integrated-hiv-program-report-2018-q2", |
| "package_id": "b876976a-adfe-4c30-aef2-f11b31e7f918", | | "package_id": "b876976a-adfe-4c30-aef2-f11b31e7f918", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "e71da087ac6116fe982280115cb76a1bee9ac04cff5f8132dd5b0a03e7e1ca45", | | "e71da087ac6116fe982280115cb76a1bee9ac04cff5f8132dd5b0a03e7e1ca45", |
| "size": 4964346, | | "size": 4964346, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| b8cb881528/download/malawi-integrated-hiv-program-report-2018-q2.pdf", | | b8cb881528/download/malawi-integrated-hiv-program-report-2018-q2.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2018 Q2", | | "title": "Malawi Integrated HIV Program Report 2018 Q2", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2018" | | "year": "2018" |
| } | | } |